Profile Image
Daniel Dilling Photo
Daniel Dilling
Primary Department
Pulmonary and Critical Care Medicine
Lung Disease
Lung Transplantation
Alpha-1 Antitrypsin Deficiency
Lymphangioleiomyomatosis (LAM)
Pulmonary Fibrosis
Critical Care
Interstitial Lung Disease
Birt–Hogg–Dubé lung disease
Sjögren's Interstitial Lung Disease
Cystic Lung Disease
Langerhans cell histiocytosis pulmonary disease
Eosinophilic Granuloma of the lung
Pulmonary alveolar proteinosis
Hermansky–Pudlak syndrome
Rare Lung Diseases
Lung Transplant
Loyola Hospital
Loyola Outpatient Center
RML Specialty Hospital
Medical School
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center, Internal Medicine: General
Loyola University Medical Center, Pulmonary and Critical Care Medicine
Notre Dame Football
Live Music
Family Time
Newton, CA; Oldham, JM; Applegate, C; Carmichael, N; Powell, K; Dilling, D; Schmidt, SL; Scholand, MB; Armanios, M; Garcia, CK; Kropski, J; Talbert, JThe Role of Genetic Testing in Pulmonary Fibrosis: A Perspective from the Pulmonary Fibrosis Foundation Genetic Testing Work Group. Chest 2022 ;
Mallea, JM; Hartwig, MG; Keller, CA; Kon, Z; Iii, RNP; Erasmus, DB; Roberts, M; Patzlaff, NE; Johnson, D; Sanchez, PG; D'Cunha, J; Brown, AW; Dilling, DF; McCurry, KRemote ex vivo lung perfusion at a centralized evaluation facility. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2022 ;
Warrior, K; Dilling, DFLung transplantation for lymphangioleiomyomatosis. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2022 ;
Swaminathan, A; Hellkamp, AS; Neely, ML; Bender, S; Paoletti, L; White, ES; Palmer, SM; Whelan, TP; Dilling, DFDisparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry. Annals of the American Thoracic Society 2022 ;
Warrior, K; Leard, LE; Nair, AR; Gries, CJ; Fisher, AJ; Johnson, SR; McCormack, FX; Dilling, DFA survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant. Respiratory medicine 2022 ;195
Thomas, A; Sumughan, S; Dellacecca, ER; Shivde, RS; Lancki, N; Mukhatayev, Z; Vaca, CC; Han, F; Barse, L; Henning, SW; Zamora-Pineda, J; Akhtar, S; Gupta, N; Zahid, JO; Zack, SR; Ramesh, P; Jaishankar, D; Lo, AS; Moss, J; Picken, MM; Darling, TN; Scholtens, DM; Dilling, DF; Junghans, RP; Le Poole, ICBenign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice. JCI insight 2021 ;6(22)
Kuczewski, M; Wasson, K; Hutchison, PJ; Dilling, DFPutting ethics and clinical decision making before politics: requiring COVID-19 immunization for Solid Organ Transplantation (SOT) Candidates and their Support Team. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2021 ;
Baldi, BG; Radzikowska, E; Cottin, V; Dilling, DF; Ataya, A; Ribeiro Carvalho, CR; Harari, S; Koslow, M; Grutters, JC; Inoue, Y; Gupta, N; Johnson, SRCOVID-19 in lymphangioleiomyomatosis: an international study of outcomes and impact of mTOR inhibition. Chest 2021 ;
Crespo, MM; Lease, ED; Sole, A; Sandorfi, N; Snyder, LD; Berry, GJ; Pavec, JL; Venado, AE; Cifrian, JM; Goldberg, H; Dilling, DF; Gries, C; Nair, A; Willie, K; Meyer, KC; Shah, RJ; Tokman, S; Holm, A; Patterson, CM; McWilliams, T; Shtraichman, O; Bemiss, B; Salgado, J; Farver, C; Strah, H; Wassilew, K; Kaza, V; Howsare, M; Murray, M; Bhorade, S; Budev, MISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2021 ;
Martinez, FJ; Yow, E; Flaherty, KR; Snyder, LD; Durheim, MT; Wisniewski, SR; Sciurba, FC; Raghu, G; Brooks, MM; Kim, DY; Dilling, DF; Criner, GJ; Kim, H; Belloli, EA; Nambiar, AM; Scholand, MB; Anstrom, KJ; Noth, IEffect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. JAMA 2021 ;325(18)
Dilling, DHiding in Plain Sight: A Tool to Reveal Undiagnosed ILD in Our PFT Labs. Chest 2020 ;158(2)
Chung, PA; Dilling, DFImmunosuppressive strategies in lung transplantation. Annals of translational medicine 2020 ;8(6)
Han, F; Dellacecca, ER; Barse, LW; Cosgrove, C; Henning, SW; Ankney, CM; Jaishankar, D; Yemelyanov, A; Krymskaya, VP; Dilling, DF; Le Poole, ICAdoptive T-Cell Transfer to Treat Lymphangioleiomyomatosis. American journal of respiratory cell and molecular biology 2020 ;62(6)
Case, AH; Hellkamp, AS; Neely, ML; Bender, S; Dilling, DF; Gulati, M; Hotchkin, DL; Huie, TJ; Lancaster, L; Snyder, LD; Conoscenti, CS; Palmer, SMAssociations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry. Annals of the American Thoracic Society 2020 ;17(6)
Nolley, E; Fleck, J; Kavalieratos, D; Dew, MA; Dilling, D; Colman, R; Crespo, MM; Goldberg, H; Hays, S; Hachem, R; Lease, E; Lee, J; Reynolds, J; Morrell, M; Schenker, YLung Transplant Pulmonologists' Views of Specialty Palliative Care for Lung Transplant Recipients. Journal of palliative medicine 2020 ;23(5)
Van Raemdonck, D; Keshavjee, S; Levvey, B; Cherikh, WS; Snell, G; Erasmus, M; Simon, A; Glanville, AR; Clark, S; D'Ovidio, F; Catarino, P; McCurry, K; Hertz, MI; Venkateswaran, R; Hopkins, P; Inci, I; Walia, R; Kreisel, D; Mascaro, J; Dilling, DF; Camp, P; Mason, D; Musk, M; Burch, M; Fisher, A; Yusen, RD; Stehlik, J; Cypel, MDonation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2019 ;38(12)
Crow, LD; Jambusaria-Pahlajani, A; Chung, CL; Baran, DA; Lowenstein, SE; Abdelmalek, M; Ahmed, RL; Anadkat, MJ; Arcasoy, SM; Berg, D; Bibee, KP; Billingsley, E; Black, WH; Blalock, TW; Bleicher, M; Brennan, DC; Brodland, DG; Brown, MR; Carroll, BT; Carucci, JA; Chang, TW; Chaux, G; Cusack, CA; Dilling, DF; Doyle, A; Emtiazjoo, AM; Ferguson, NH; Fosko, SW; Fox, MC; Goral, S; Gray, AL; Griffin, JR; Hachem, RR; Hall, SA; Hanlon, AM; Hayes, D; Hickey, GW; Holtz, J; Hopkins, RS; Hu, J; Huang, CC; Brian Jiang, SI; Kapnadak, SG; Kraus, ES; Lease, ED; Leca, N; Lee, JC; Leitenberger, JJ; Lim, MA; Longo, MI; Malik, SM; Mallea, JM; Menter, A; Myers, SA; Neuburg, M; Nijhawan, RI; Norman, DJ; Otley, CC; Paek, SY; Parulekar, AD; Patel, MJ; Patel, VA; Patton, TJ; Pugliano-Mauro, M; Ranganna, K; Ravichandran, AK; Redenius, R; Roll, GR; Samie, FH; Shin, T; Singer, JP; Singh, P; Soon, SL; Soriano, T; Squires, R; Stasko, T; Stein, JA; Taler, SJ; Terrault, NA; Thomas, CP; Tokman, S; Tomic, R; Twigg, AR; Wigger, MA; Zeitouni, NC; Arron, STInitial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. Transplant international : official journal of the European Society for Organ Transplantation 2019 ;32(12)
Wajda, N; Zhu, Z; Jandarov, R; Dilling, DF; Gupta, NClinical outcomes and survival following lung transplantation in patients with pulmonary Langerhans cell histiocytosis. Respirology (Carlton, Vic.) 2019 ;25(6)
Formanek, PE; Dilling, DFAdvances in the Diagnosis and Management of Invasive Fungal Disease. Chest 2019 ;156(5)
Khawar, MU; Yazdani, D; Zhu, Z; Jandarov, R; Dilling, DF; Gupta, NClinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2019 ;38(9)
Patel, NM; Kulkarni, T; Dilling, D; Scholand, MBPreoperative Evaluation of Patients With Interstitial Lung Disease. Chest 2019 ;156(5)
Dilling, DThe National Heart, Lung, and Blood Institute Lymphangioleiomyomatosis Registry: Making LAMonade out of LAMons. Chest 2019 ;155(2)
Swigris, JJ; Brown, KK; Abdulqawi, R; Buch, K; Dilling, DF; Koschel, D; Thavarajah, K; Tomic, R; Inoue, YPatients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases. European respiratory review : an official journal of the European Respiratory Society 2018 ;27(150)
Dilling,D. F.The 10,000-Piece Puzzle of Lymphangioleiomyomatosis Chest 2018 ;153(2):298-299
Young, KA; Dilling, DFAhead of the Curve: The Future of Lung Transplantation. Chest 2018 ;
Rynar, LZ; Merchant, MS; Dilling, DFSuicidal ideation in lung transplant recipients: A case series. Clinical transplantation 2018 ;32(6)
Dilling,D. F.First Spontaneous Pneumothorax: Time for Screening High-Resolution Computed Tomographic Imaging to Look for Cystic Lung Disease? Annals of the American Thoracic Society 2017 ;14(1):12-13
Eby,J. M.; Barse,L.; Henning,S. W.; Rabelink,M. J.; Klarquist,J.; Gilbert,E. R.; Hammer,A. M.; Fernandez,M. F.; Yung,N.; Khan,S.; Miller,H. G.; Kessler,E. R.; Garrett-Mayer,E.; Dilling,D. F.; Hoeben,R. C.; Le Poole,I. C.Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice Cancer immunology, immunotherapy : CII 2017 ;66(1):63-75
Lu,C.; Lee,H. S.; Pappas,G. P.; Dilling,D. F.; Burger,C. D.; Shifren,A.; Veeraraghavan,S.; Chapman,J. T.; Parambil,J.; Ruoss,S. J.; Young,L. R.; Hammes,S. R.; Kopras,E. J.; Roads,T.; Krischer,J. P.; McCormack,F. X.; Trial of an Aromatase Inhibitor in Lymphangioleiomyomatosis GroupA Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis Annals of the American Thoracic Society 2017 ;14(6):919-928
Bharat,A.; Cunningham,S. A.; Scott Budinger,G. R.; Kreisel,D.; DeWet,C. J.; Gelman,A. E.; Waites,K.; Crabb,D.; Xiao,L.; Bhorade,S.; Ambalavanan,N.; Dilling,D. F.; Lowery,E. M.; Astor,T.; Hachem,R.; Krupnick,A. S.; DeCamp,M. M.; Ison,M. G.; Patel,R.Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans Science translational medicine 2015 ;7(284):284re3
Gottlieb,J.; Zamora,M. R.; Hodges,T.; Musk,A. W.; Sommerwerk,U.; Dilling,D.; Arcasoy,S.; DeVincenzo,J.; Karsten,V.; Shah,S.; Bettencourt,B. R.; Cehelsky,J.; Nochur,S.; Gollob,J.; Vaishnaw,A.; Simon,A. R.; Glanville,A. R.ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2015 ; :
Gupta,N.; Meraj,R.; Tanase,D.; James,L. E.; Seyama,K.; Lynch,D. A.; Akira,M.; Meyer,C. A.; Ruoss,S. J.; Burger,C. D.; Young,L. R.; Almoosa,K. F.; Veeraraghavan,S.; Barker,A. F.; Lee,A. S.; Dilling,D. F.; Inoue,Y.; Cudzilo,C. J.; Zafar,M. A.; McCormack,F. X.Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases The European respiratory journal 2015 ;46(4):1196-1199
Gagermeier,J. P.; Rusinak,J. D.; Lurain,N. S.; Alex,C. G.; Dilling,D. F.; Wigfield,C. H.; Love,R. B.Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients Transplant infectious disease : an official journal of the Transplantation Society 2014 ;16(6):941-950
Lowery,E. M.; Kuhlmann,E. A.; Mahoney,E. L.; Dilling,D. F.; Kliethermes,S. A.; Kovacs,E. J.Heavy alcohol use in lung donors increases the risk for primary graft dysfunction Alcoholism, Clinical and Experimental Research 2014 ;38(11):2853-2861
Covey,M. K.; Collins,E. G.; Reynertson,S. I.; Dilling,D. F.Resistance training as a preconditioning strategy for enhancing aerobic exercise training outcomes in COPD Respiratory medicine 2014 ;108(8):1141-1152
Gilbert,E. R.; Eby,J. M.; Hammer,A. M.; Klarquist,J.; Christensen,D. G.; Barfuss,A. J.; Boissy,R. E.; Picken,M. M.; Love,R. B.; Dilling,D. F.; Le Poole,I. C.Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis The American journal of pathology 2013 ;183(1):226-234
Dilling,D. F.; Gilbert,E. R.; Picken,M. M.; Eby,J. M.; Love,R. B.; Le Poole,I. C.A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment options American Journal of Respiratory Cell & Molecular Biology 2012 ;46(1):1-5
Fisichella,P. M.; Davis,C. S.; Shankaran,V.; Gagermeier,J.; Dilling,D.; Alex,C. G.; Kovacs,E. J.; Joehl,R. J.; Love,R. B.The prevalence and extent of gastroesophageal reflux disease correlates to the type of lung transplantation. Surgical laparoscopy, endoscopy & percutaneous techniques 2012 ;22(1):46-51
Fisichella,P. M.; Davis,C. S.; Gagermeier,J.; Dilling,D.; Alex,C. G.; Dorfmeister,J. A.; Kovacs,E. J.; Love,R. B.; Gamelli,R. L.Laparoscopic antireflux surgery for gastroesophageal reflux disease after lung transplantation. Journal of Surgical Research 2011 ;170(2):e279-86
Dilling,D. F.; Glanville,A. R.Advances in lung transplantation: the year in review Journal of Heart & Lung Transplantation 2011 ;30(3):247-251
Davis,C. S.; Gagermeier,J.; Dilling,D.; Alex,C.; Lowery,E.; Kovacs,E. J.; Love,R. B.; Fisichella,P. M.A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population Clinical transplantation 2010 ;24(3):E54-61
Davis,C. S.; Shankaran,V.; Kovacs,E. J.; Gagermeier,J.; Dilling,D.; Alex,C. G.; Love,R. B.; Sinacore,J.; Fisichella,P. M.Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment. Surgery 2010 ;148(4):737-744
Klarquist,J.; Barfuss,A.; Kandala,S.; Reust,M. J.; Braun,R. K.; Hu,J.; Dilling,D. F.; McKee,M. D.; Boissy,R. E.; Love,R. B.; Nishimura,M. I.; Le Poole,I. C.Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells. American Journal of Pathology 2009 ;175(6):2463-2472
Dilling,D.Diagnostic criteria for persistent vegetative state. VIRTUAL MENTOR 2007 ;9(5):359